Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

CNS Diseases - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• GEN Podcasts
• BLOG Biotech
• New Products
• Best Of The Web
• Events

GEN articles

• Feature Articles: miRNAs & Psychiatric Disorders
  
• Feature Articles: Promoting Neuron Survival in CNS Diseases
  Instead of Fighting Cell-Death Mechanisms, Clavulanic Acid Seeks to Fortify Cell Defenses
• Feature Articles: Neuroscience Benefits from Cash Infusion
  NIH Commits $30 Million to Mapping Circuitry of the Brain Using Imaging Technologies
• Feature Articles: Strategies to Overcome Blood-Brain Barrier
  Complex Biology of CNS Diseases Continues to Hamper Development of Effective Drugs
• Corporate Profiles: BrainCells Bets on Small Molecule Therapies
  Firm’s Screening Device Provides Fingerprint of a Compound’s Neurogenic Profile

• MORE CNS DISEASES RELATED GEN ARTICLES

Insight & intelligence™

• Stakeholders Share Data to Design Better Trials for Neurodegenerative Diseases
  May 15, 2012
  The Coalition Against Major Diseases is pooling clinical data to build disease and drug models.
• Firms Are Trying to Untangle Alzheimer Drug Development with mAbs
  April 24, 2012
  AD remains one of few therapeutic areas with blockbluster potential.
• Search for New Analgesics Worth the Pain Given Side Effects of Opioids
  April 3, 2012
  Researchers are targeting different pathways with small and large molecules in their quest for a new pain killer.
• FDA, IOM Point to Need to Ramp Up Development of Abuse-Resistant and Novel Nonopioid Pain Meds
  April 2, 2012
  Suggestions include public-private partnerships as a way to fund R&D in this area.
• Genomic Studies Are Adding to Evidence of Autism’s Highly Complex Nature
  November 1, 2011
  As research unravels more genetic clues, it also reveals how tough drug R&D is going to be.

• MORE CNS DISEASES RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• Shire Reports Positive Phase III Data to Support European Filing of ADHD Drug Vyvanse
  
• CHDI, Lundbeck Partner for Preclinical Studies with Huntington Disease Candidate
  
• MSC-Secreted Factor Key to Impact of Multiple Sclerosis Cell Therapy
  
• ALS Institute, Neurotune to Evaluate Amyotrophic Lateral Sclerosis Therapeutic Candidate
  
• KineMed, CHDI Ally on Biomarkers of Huntington Disease Progression, Drug Efficacy
  

• MORE CNS DISEASES RELATED GEN NEWS HIGHLIGHTS

GEN podcasts

• DELIVERING CELLS INTRANASALLY TO THE BRAIN
  - Interview with William Frey, Co-Director, Alzheimer's Research Center, Regions Hospital, St. Paul, MN, and Professor, Oral Biology and Pharmaceutics, University of Minnesota
• CLEAR GENETIC LINK BETWEEN IMMUNE AND NERVOUS SYSTEMS ESTABLISHED
  - Interview with Alejandro Aballay, Ph.D., Assistant Professor, Department of Molecular Genetics and Microbiology, Duke University Medical School
• NOVEL METHOD FOR REMYELINATING NERVE CELLS
  - Interview with Steve Goldman, M.D., Ph.D., Professor of Neurology and Chief of the Division of Cell and Gene Therapy at the University of Rochester Medical Center
• GENE THERAPY FOR FATAL NEURODEGENERATIVE DISEASE IN CHILDREN
  - Interview with Ronald G. Crystal, M.D., Professor and Chairman of the Department of Genetic Medicine of the Weill Medical College of Cornell University
• DISCOVERY OF A CHEMICAL SIGNATURE IN THE BRAIN FOR MANIC DEPRESSION
  - Interview with Tsz Tsang, Ph.D., Department of Biomolecular Medicine, Imperial College London

• MORE CNS DISEASES RELATED GEN PODCASTS

BLOG biotech

• 2-to-1 Majority Envisions Personalized Medicine Approach to Autism, ASDs
  

• VIEW BY SUBJECT | MORE CNS DISEASES RELATED BLOG BIOTECH

New products

	GigaCyte Human Hippocampal Stem Cells These human hippocampal stem cells have been launched for use in neuroscience and cytotoxicity testing. These cells have been extensively characterized for neural stem cell and mature neural markers. This human organ-derived product differentiates i
	NextGen CNS Biomarker Assay The csfdiscovery43 cerebrospinal fluid (CSF) multiplex assay is for central nervous system (CNS) biomarker discovery and qualification. The assay simultaneously measures 43 human CSF proteins that are thought to have potential as biomarkers in CNS d
	Sigma-Aldrich Corporation Neurobiology Antibody Array The Panorama® neurobiology antibody array is a proteomics tool to measure the relative level of protein expression in cell or tissue extracts. The array contains 224 human antibodies spotted in duplicate on a nitrocellulose-coated glass slide th

• MORE CNS DISEASES RELATED NEW PRODUCTS

Best of the web

• Click and Learn
  
• Nerve Whiz (University of Michigan)
  
• 3D Brain (Cold Spring Harbor Laboratory)
  
• Open Optogenetics
  
• NIF (Neuroscience Information Framework)
  

• MORE CNS DISEASES RELATED BEST OF THE WEB

Events

• Molecular Neurology and Therapeutics
  2012 July 7 - July 14 Cambridge, , UNITED KINGDOM

• MORE CNS DISEASES RELATED EVENTS

Home | Terms of Use | Privacy Statement | Legal